Orforglipron vs Retatrutide: Does the Pill Beat the Triple Agonist?
Orforglipron (Eli Lilly's oral GLP-1) vs retatrutide TRIPLE-G. Pill convenience vs triple agonist efficacy: clinical data compared.
Detailed comparisons between major peptides for metabolic research.
Survodutide (dual GLP-1/glucagon agonist) vs retatrutide TRIPLE-G (triple agonist). Efficacy, mechanism, clinical data and results compared.
Ozempic vs Mounjaro vs Retatrutide: 1, 2 or 3 receptors? Comparison based on NEJM trials with tables and costs. Find your generation.
Comparison of the three leading GLP-1 peptides: semaglutide, tirzepatide and retatrutide. Mechanism, efficacy and development status.
Ranking of the most promising peptides for weight loss research in 2026: retatrutide, tirzepatide, semaglutide, survodutide, and CagriSema.
How GLP-1 peptides affect body composition: fat mass vs lean mass ratio, effects on muscle, and strategies to optimize results.